Celularity Inc - CELU Book Capitalization
Celularity Inc. (CELU) specializes in developing immune-boosting drugs. This price chart demonstrates volatility, as revenue stability currently depends on clinical trial results, and the indicator stands at -0.04. Risks are linked to reporting delays and high cash burn, which erode confidence in management. Meanwhile, Celularity Inc. (CELU) aims to increase biomaterial sales to reduce its reliance on external financing.
%20Company%20Book%20Value&width=1200&height=400&colorIndex=0&v=mvq8bmkb.8d-7aozthc&start=20220704&end=20261027&filename=GURU_Markets_-_CELU_-_Celularity-Inc._-_Company-Book-Value "Celularity Corp (CELU): Net Asset Value from 07/04/2022 to 10/27/2026 | 👁️GURU.Markets👁️")
Metric breakdowns and analytics for Celularity Corp (CELU)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Fundamental valuation:CELU - Celularity
The assessment of fundamental capital risks begins with an analysis of the residual asset value after all liabilities are settled. For Celularity Inc. (CELU), whose model relies on external financing due to a lack of commercial products, the current book capitalization figure of -0.04 reflects the actual margin of financial stability, allowing investors to evaluate the company's ability to sustain clinical trials amidst negative cash flow.
Competitor analysis for Celularity Inc.
argenx BVBA (ARGX) - Company Book Value|BNTX: Company Net Assets|ABVX (ABIVAX) - Book Capitalization|Company Book Value ADMA Biologics, Inc. ADMA|Net Asset Value Protagonist Therapeutics, Inc.|Immunovant Corp (IMVT) - Book Capitalization|Accounting Value of Company Kiniksa Corp (KNSA)|Book Capitalization GRFS (Grifols, S.A.)|adaptivebiotech.com - Book Capitalization|Company Book Value Celldex Therapeutics, Inc. (CLDX)|AUPH: Accounting Value of Company|BCRX (BioCryst Pharmaceuticals Inc) - Company Book Value|Vera Corp (VERA) - Company Net Assets|DNTH (Dianthus Therapeutics) - Book Capitalization|Book Capitalization pharvaris.com (PHVS)|AbCellera Bio (ABCL) - Company Net Assets|Accounting Value of Company Tourmaline Bio Inc (TRML)|Book Capitalization PGEN|Pharming Corp - Book Valuation of Business|NKTR: Company Book Value|UPB: Company Net Assets|ZBIO (Zenas Biopharma) - Company Book Value|Company Net Assets Immunome Inc|GOSS (Gossamer Corp) - Company Net Assets|Book Capitalization KALV|Company Book Value Septerna Inc SEPN|Accounting Capitalization pieris.com (PVLA)|SVRA: Book Capitalization|Total Stockholders' Equity Rigel Pharma RIGL|ANAB: Book Capitalization|ATXS - Company Net Assets|Book Capitalization ENGN|RAPT (rapt.com) - Total Stockholders' Equity|Company Book Value Aerovate Therapeutics, Inc.|Company Book Value Aclaris Therapeutics Inc. (ACRS)|Company Net Assets KYTX|Book Capitalization TLSA (Tiziana Life Sciences, Ltd.)|Company Book Value Cabaletta Bio, Inc. CABA|Company Book Value ventyxbio.com VTYX|Theratechnologies - Book Capitalization|AVTX: Book Capitalization|Company Book Value Eledon ELDN|Agenus, Inc (AGEN) - Accounting Value of Company|CLYM: Book Capitalization|Book Valuation of Business zurabio.com (ZURA)|Company Net Assets aTyr Pharma|Total Net Assets adagene.com ADAG|IMA: Company Net Assets|STTK - Total Stockholders' Equity|Company Net Assets Equillium Bio (EQ)|CNTB - Accounting Value of Company|immunic-therapeutics.com - Book Capitalization|ATRA (Atara Bio) - Book Valuation of Business|Company Book Value InflaRx NV (IFRX)|Accounting Capitalization X4 Pharmaceuticals, Inc|Book Capitalization ACET (Adicet Bio)|Company Net Assets inmunebio.com INMB|Company Net Assets BRNS|Book Valuation of Business Kezar Life Sciences Inc. KZR|SABS: Book Capitalization|AKTX - Company Net Assets|Book Capitalization ENLV|QTTB (Q32 Bio) - Total Stockholders' Equity|Company Book Value GeoVax|Company Book Value Edesa Biotech Inc (EDSA)|Company Net Assets IBIO|Book Capitalization CARM (carismatx.com)|XTL Biopharmaceuticals (XTLB) - Company Book Value|Net Asset Value Bolt Biotherapeutics Inc. BOLT|Book Capitalization HCW Biologics Inc (HCWB)|APVO - Accounting Value of Company|AIM: Book Capitalization|ADTX (Aditxt, Inc.) - Book Capitalization|GRI - Company Book Value|Accounting Value of Company XRTX|Company Book Value HIND (Vyome Holdings)|Company Net Assets Revelation Biosciences Inc (REVB)|Book Capitalization INDP (Indaptus)|SCNI - Book Capitalization|Company Net Assets CalciMedica Corp (CALI)|AFMD - Accounting Value of Company|allakos.com - Book Capitalization|HOOK (HOOKIPA Pharma) - Book Valuation of Business|Company Book Value IGMS|Company Net Assets ITOS|Company Book Value OCEA (Ocean Biomedical, Inc.)|Company Net Assets tcbiopharm.com TCBP|Company Net Assets THRD (Third Harmonic Bio, Inc.)